HS-10353

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HS-10353, covering 2023-07-10 to 2023-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-10353 in Adult Participants With Major Depressive Disorder [Phase 2]